SARS-CoV-2, Influenza A&B Antigen Combined Detection Kit-EU CE

ʻO COVID-19, Flu A a i ʻole Flu B kaʻana like i nā hōʻailona like, he mea paʻakikī ke hoʻokaʻawale i waena o nā maʻi maʻi ʻekolu.

Ka Pono

He mea koʻikoʻi ka ʻike ʻokoʻa pololei e alakaʻi i ka lāʻau antiviral kūpono.

ʻOiai ke kaʻana like ʻana i nā hōʻailona like, COVID-19, Flu A a me Flu B pono nā lāʻau antiviral like ʻole.Hiki ke mālama ʻia ka maʻi maʻi me nā neuraminidase inhibitors a me COVID-19 koʻikoʻi me ka remdesivir/sotrovimab.

ʻAʻole manaʻo ka hopena maikaʻi i ka maʻi hoʻokahi ua kaʻawale ʻoe mai nā mea ʻē aʻe.Hoʻonui ka co-infections i nā pilikia o ka maʻi koʻikoʻi, ka halemai, ka make ma muli o nā hopena synergistic.

He mea koʻikoʻi ka hōʻoia pololei ʻana ma o ka hoʻāʻo multiplex e alakaʻi i ka lāʻau antiviral kūpono, ʻoi aku hoʻi me nā co-infections i ka wā kiʻekiʻe o ka hanu hanu.

ʻO kā mākou hoʻonā

ʻO ka Macro & Micro-TestSARS-CoV-2, Influenza A&B Antigen Combined Detection, hoʻokaʻawale i ka Flu A, Flu B a me COVID-19 me nā maʻi maʻi he nui i ka wā o ka maʻi hanu;

ʻO ka hoʻāʻo wikiwiki ʻana i nā maʻi hanu he nui, me SARS-CoV-2, Flu A, a me Flu B e hoʻokahi laʻana;

Hoʻohui piha ka pahu ho'āʻo me hoʻokahi wale nō wahi noi a hoʻokahi laʻana e pono ai e hoʻokaʻawale i waena o Covid-19, Flu A a me Flu B;

4 ʻanuʻu wale no ka wikiwiki nā hopena i loko o 15-20 min wale nō, e hiki ai i ka hoʻoholo hoʻoholo lāʻau wikiwiki.

Nui nā ʻano laʻana: Nasopharyngeal, Oropharyngeal a i ʻole Nasal;

Mahana Waihona: 4 -30°C;

Paʻa Ola: 24 mahina.

Nui nā hiʻohiʻona e like me nā halemai, nā keʻena hauʻoli, nā kikowaena olakino kaiāulu, nā lāʻau lapaʻau, etc.

	SARS-CoV-2	Flu A	FluB
ʻO ka ʻike	94.36%	94.92%	93.79%
kikoo	99.81%	99.81%	100.00%
Ka pololei	98.31%	98.59%	98.73%